FY2027 EPS Estimates for Novavax Reduced by Zacks Research
Novavax, Inc. (NASDAQ:NVAX – Free Report) – Equities researchers at Zacks Research dropped their FY2027 EPS estimates for Novavax in a note issued to investors on Monday, April 14th. Zacks Research analyst S. Ganoria now forecasts that the biopharmaceutical company will post earnings per share of $0.51 for the year, down from their previous estimate […]
Novavax, Inc. (NASDAQ:NVAX – Free Report) – Equities researchers at Zacks Research dropped their FY2027 EPS estimates for Novavax in a note issued to investors on Monday, April 14th. Zacks Research analyst S. Ganoria now forecasts that the biopharmaceutical company will post earnings per share of $0.51 for the year, down from their previous estimate […]
